Editorial Comment: A Case Definition for HIV Lipodystrophy - A Work in Progress

AIDS Reader

Volumn 13, Issue 10, 2003, Pages 492-493

  Wanke, Christine ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BODY COMPOSITION; BODY FAT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LIPODYSTROPHY; NOTE; SYNDROME DELINEATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; CLASSIFICATION; HIV ASSOCIATED LIPODYSTROPHY; HOSPITALIZATION; PATHOPHYSIOLOGY;

HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 0242380243     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (1)

1. Puls R, Carr A. Practical applications of the HIV lipodystrophy case definition. AIDS Reader. 2003;13:480-493.